Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids

Part of paid clinical trials in Detroit, Michigan.

Sponsor
Wayne State University
Study ID
NCT06297278
Status
Recruiting

Conditions

  • Adolescence

Eligibility Criteria

Sex
ALL
Age
14 Years - 17 Years
Healthy Volunteers
Accepted

Interventions

  • Moderate Intensity Exercise — BEHAVIORAL
    Participants randomized to the active (moderate intensity) exercise condition will complete a 3-minute warm-up at low speed on a treadmill. Speed and incline will be increased in 3-minute increments until moderate-intensity exercise, defined as participants staying within a zone of 60-80% AAMHR with the target being to attain and maintain 70-75% AAMHR while briskly walking and/or jogging depending on current fitness status, is reached for a total of 30 min.

Study Details

Anxiety disorders commonly begin during adolescence, and are characterized by deficits in the ability to inhibit or extinguish pathological fear. Recent research has provided new understanding of how fear is learned and can be regulated in the adolescent brain, and how the endocannabinoid system shapes these processes; however, these advances have not yet translated into improved therapeutic outcomes for adolescents with anxiety. This study will test whether a behavioral intervention, acute exercise, can help to improve fear regulation by enhancing brain activity and endocannabinoid signaling. This line of research may ultimately lead to more effect treatments for adolescent anxiety, and to new preventive strategies for at-risk youth.

Key Dates

Start date
May 17, 2024
Status verified
Aug 2025
Primary completion
Apr 30, 2028
Completion
Apr 30, 2028

Study Design

Enrollment
174 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Moderate Intensity Exercise
  • No Intervention: Control (Coloring)

Primary Outcome Measure

Skin Conductance Responding (SCR) [ Time Frame: Throughout study completion (3 days) ]

Locations (1)

FacilityCityStateZIPSite coordinators
Tolan Park Medical BuildingDetroitMichigan48201
MacKenna Shampine
313-242-7464‬

Find similar trials in Detroit, MI

Related Studies